These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38128460)

  • 1. Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.
    Miskowiak KW; Petersen JZ; Macoveanu J; Ysbæk-Nielsen AT; Lindegaard IA; Cramer K; Mogensen MB; Hammershøj LG; Stougaard ME; Jørgensen JL; Schmidt LS; Vinberg M; Ehrenreich H; Hageman I; Videbech P; Gbyl K; Kellner CH; Kessing LV; Jørgensen MB
    Eur Neuropsychopharmacol; 2024 Feb; 79():38-48. PubMed ID: 38128460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.
    Macoveanu J; Petersen JZ; Mariegaard J; Jespersen AE; Cramer K; Bruun CF; Madsen HØ; Jørgensen MB; Vinberg M; Fisher PM; Knudsen GM; Hageman I; Ehrenreich H; Kessing LV; Miskowiak KW
    J Psychopharmacol; 2024 Apr; 38(4):362-374. PubMed ID: 38519416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
    Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
    Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
    Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
    Miskowiak KW; Macoveanu J; Vinberg M; Assentoft E; Randers L; Harmer CJ; Ehrenreich H; Paulson OB; Knudsen GM; Siebner HR; Kessing LV
    Acta Psychiatr Scand; 2016 Sep; 134(3):249-59. PubMed ID: 27259062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression.
    Rong H; Xu SX; Zeng J; Yang YJ; Zhao J; Lai WT; Chen LC; Deng WF; Zhang X; Zhang YL; Li MZ; Xiao L; Xie XH
    BMC Psychiatry; 2019 Nov; 19(1):344. PubMed ID: 31694611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.
    Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH
    J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural correlates of episodic memory decline following electroconvulsive therapy: An exploratory functional magnetic resonance imaging study.
    Petersen JZ; Macoveanu J; Ysbæk-Nielsen AT; Kessing LV; Jørgensen MB; Miskowiak KW
    J Psychopharmacol; 2024 Feb; 38(2):168-177. PubMed ID: 38159102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
    Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
    Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autobiographical and subjective memory with right unilateral high-dose 0.3-millisecond ultrabrief-pulse and 1-millisecond brief-pulse electroconvulsive therapy: a double-blind, randomized controlled trial.
    Mayur P; Byth K; Harris A
    J ECT; 2013 Dec; 29(4):277-82. PubMed ID: 24263273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder.
    Nuninga JO; Claessens TFI; Somers M; Mandl R; Nieuwdorp W; Boks MP; Bakker S; Begemann MJH; Heringa S; Sommer IEC
    J Affect Disord; 2018 Oct; 238():659-665. PubMed ID: 29966930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
    Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
    Trials; 2010 Oct; 11():97. PubMed ID: 20942940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression.
    Kessler U; Schoeyen HK; Andreassen OA; Eide GE; Malt UF; Oedegaard KJ; Morken G; Sundet K; Vaaler AE
    J Clin Psychiatry; 2014 Nov; 75(11):e1306-13. PubMed ID: 25470096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
    Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
    J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.
    Loo CK; Katalinic N; Garfield JB; Sainsbury K; Hadzi-Pavlovic D; Mac-Pherson R
    J Affect Disord; 2012 Dec; 142(1-3):233-40. PubMed ID: 22858219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trial.
    Dominiak M; Antosik-Wójcińska AZ; Goetz Z; Sikorska O; Stefanowski B; Gorostiza D; Święcicki Ł
    J Psychiatr Res; 2021 Jan; 133():52-59. PubMed ID: 33310500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive training to improve memory in individuals undergoing electroconvulsive therapy: Negative findings.
    Choi J; Wang Y; Feng T; Prudic J
    J Psychiatr Res; 2017 Sep; 92():8-14. PubMed ID: 28376409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.